Tim Vanmierlo Selected Research

N(6)-(1-carboxyethyl)lysine

4/2018

Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Vanmierlo Research Topics

Disease

12	Multiple Sclerosis 11/2021 - 03/2014
11	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 01/2010
7	Inflammation (Inflammations) 11/2021 - 03/2012
6	Neuroinflammatory Diseases 11/2021 - 01/2017
4	Cognitive Dysfunction 01/2021 - 01/2012
4	Disease Progression 04/2018 - 01/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 08/2013
3	Demyelinating Diseases (Demyelinating Disease) 05/2021 - 01/2018
2	Brain Injuries (Brain Injury) 05/2021 - 12/2019
2	Wounds and Injuries (Trauma) 11/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 09/2011
2	Hypercholesterolemia 01/2017 - 09/2011
2	Amyloid Plaque 10/2013 - 01/2010
2	Atherosclerosis 06/2011 - 06/2011
1	Pain (Aches) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Osteoarthritis 01/2022
1	Ischemic Stroke 06/2021
1	Neoplasms (Cancer) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Atrophy 01/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Cicatrix (Scar) 11/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 12/2019
1	Autoimmune Diseases of the Nervous System 04/2018
1	Glucose Intolerance 01/2018
1	Iron Deficiencies 06/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Insulin Resistance 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2016
1	Memory Disorders (Memory Loss) 04/2016

Drug/Important Bio-Agent (IBA)

12	CholesterolIBA 11/2021 - 04/2006
5	Phytosterols (Plant Sterols)IBA 01/2020 - 06/2011
4	Protein Isoforms (Isoforms)IBA 11/2021 - 12/2011
4	Liver X ReceptorsIBA 11/2021 - 01/2018
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2021 - 01/2019
3	Amyloid (Amyloid Fibrils)IBA 03/2021 - 10/2013
3	RoflumilastIBA 01/2021 - 04/2016
3	Phosphodiesterase 4 InhibitorsIBA 01/2021 - 04/2016
3	Advanced Glycation End ProductsIBA 01/2019 - 02/2017
3	ApolipoproteinsIBA 01/2017 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2006
2	diethylstilbestrol monophosphate (PDES)IBA 06/2021 - 01/2021
2	Pyruvaldehyde (Methylglyoxal)IBA 01/2019 - 02/2017
2	Lipoproteins (Lipoprotein)IBA 01/2018 - 01/2017
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018 - 10/2013
2	Adenosine Triphosphate (ATP)IBA 01/2017 - 06/2011
2	LDL Receptors (LDL Receptor)IBA 01/2017 - 12/2011
2	SterolsIBA 03/2012 - 06/2011
2	Apolipoprotein E4IBA 12/2011 - 01/2011
2	campesterolIBA 09/2011 - 06/2011
2	gamma-sitosterol (beta-sitosterol)IBA 06/2011 - 04/2006
2	Messenger RNA (mRNA)IBA 01/2011 - 04/2006
1	Therapeutic UsesIBA 11/2021
1	Acrolein (Aqualin)IBA 11/2021
1	CarnosineIBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021
1	PlasticsIBA 05/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	H-cadherin (T-cadherin)IBA 01/2021
1	Dietary Advanced Glycation End ProductsIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	DisintegrinsIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	N(6)-(1-carboxyethyl)lysineIBA 04/2018
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 04/2018
1	PyridoxamineIBA 04/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2018
1	LigandsIBA 01/2018
1	Culture MediaIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	EtazolateIBA 01/2018
1	CuprizoneIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2017
1	tyrosine receptor (receptor, tyrosine)IBA 06/2017
1	IronIBA 06/2017
1	Phosphotransferases (Kinase)IBA 06/2017
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 06/2017
1	MargarineIBA 01/2017
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017
1	EstersIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 04/2016
1	Donepezil (Aricept)FDA LinkGeneric 04/2016
1	EmeticsIBA 04/2016

Therapy/Procedure

1	Arthroplasty 01/2022
1	Replantation 11/2020
1	Exercise Therapy (Therapy, Exercise) 01/2018